Hypoglycaemia in pregnant women with type 1 diabetes mellitus
- Autores: Arbatskaya N.Y.1, Tisel'ko A.V.1, Ignatova N.G.1, Arbatskaya NY.1, Tiselko AV1, Ignatova NG1
-
Afiliações:
- Edição: Nº 16 (2011)
- Páginas: 96-99
- Seção: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/279036
- ID: 279036
Citar
Texto integral
Resumo
Palavras-chave
Sobre autores
Natal'ya Arbatskaya
Alena Tisel'ko
Nadezhda Ignatova
N Arbatskaya
A Tiselko
N Ignatova
Bibliografia
- Арбатская Н.Ю. Эффективность применения программы обучения и наблюдения в комплексной терапии беременных с сахарным диабетом 1 типа. Дисс. канд. мед. наук. М., 2004. С. 129.
- Биохимия. Под редакцией Е. С. Северина. 5-е изд. ГЭОТАР-Медиа. 2011. С. 768.
- Коваленко Т.С. Беременность и инсулинзависимый сахарный диабет: прогностические критерии гестоза и исхода для плода. Автореф. дисс. канд. мед. наук. М., 2000. С. 24.
- Ланцева О. Е. Функциональная инсулинотерапия инсулинзависимого сахарного диабета во время беременности. Дисс. канд. мед. наук. СПб., 1999. С. 115.
- Федорова М.В., Краснопольский В.И., Петрухин В.А. Сахарный диабет, беременность и диабетическая фетопатия. М., Медицина, 2001. С. 288.
- Casson IF, Clarke CA, Howard CV, et al. Outcomes of pregnancy in insulin dependent diabetic women: results of a five year population cohort study. BMJ 1997;315:275-78.
- DCCT Research Group: Pregnancy outcomes in the Diabetes Control and Complications Trial. Am J Obstet Gynecol 1996;174:1343-53.
- Evers IM, de Valk HW, Visser GH. Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands. BMJ 2004;328:915.
- Hadden DR. When and how to start insulin treatment in gestational diabetes: a UK perspective. Diabet Med 2001;18:960-64.
- Hawthorne G, Robson S, Ryall EA, et al. Prospective population-based survey of outcome of pregnancy in diabetic women: results of the Northern Diabetic Pregnancy Audit 1994. BMJ 1997;315:279-81.
- Kitzmiller JL, Block JM, Brown FM, et al. Management of Preexisting Diabetes and Pregnancy. Alexandria, Virginia, American Diabetes Association, 2008.
- Lepercq J, Coste J, Theau A, et al. Factors associated with preterm delivery in women with type 1 diabetes: a cohort study. Diabetes Care 2004;27:2824-28.
- Macintosh MC, Fleming KM, Bailey JA, et al. Perinatal mortality and congenital anomalies in babies of women with type 1 or type 2 diabetes in England, Wales, and Northern Ireland: population based study. MJ 2006;333:177.
- Manderson JG, Patterson CC, Hadden DR, et al. Preprandial versus postprandial blood glucose monitoring in type 1 diabetic pregnancy: a randomized controlled clinical trial. Am J Obstet Gynecol 2003;189:507-12.
- McElvy SS, Miodovnik M, Rosenn B, et al. A focused preconceptional and early pregnancy program in women with type 1 diabetes reduces perinatal mortality and malformation rates to general population levels. J Matern Fetal Med 2000;9:14-20.
- Nielsen GL, Sorensen HT, Nielsen PH, et al. Glycosylated hemaoglobin as preictor of adverse fetal outcome in type 1 diabetic pregnancies. Acta Diabetol 1997;34:217-22.
- Rosenn BM, Miodovnik M, Holsberg G, et al. Hypoglycemia: the price of intensive insulin therapy for pregnant women with insulin dependent diabetes mellitus. Obstet Gynecol 1995; 85:417-22.
- Suhonen L, Hiilesmaa V, Teramo K. Glycemic control during early pregnancy and fetal malformations in women with type 1 diabetes mellitus. Diabetologia 2000;43:79-82.
- Temple R, Aldridge V, Greenwood R, et al. Association between outcome of pregnancy and glycaemic control in early pregnancy in type 1 diabetes: population-based study. BMJ 2002;325:1275-76.